Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,045 | -59,363 | -47,187 | 4,767 | -711 |
| Depreciation Amortization | 1,356 | 684 | 398 | N/A | N/A |
| Accounts receivable | -1,719 | -1,979 | -200 | N/A | N/A |
| Other Working Capital | -9,285 | 739 | 2,300 | 1,303 | -570 |
| Other Operating Activity | -1,150 | 9,341 | 12,376 | -7,808 | 604 |
| Operating Cash Flow | $-40,843 | $-50,578 | $-32,313 | $-1,738 | $-678 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -345 | -588 | -655 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -250,000 |
| Purchase Sale Intangibles | N/A | N/A | -131 | N/A | N/A |
| Other Investing Activity | 0 | -1,000 | -1,131 | 60 | 0 |
| Investing Cash Flow | $-345 | $-1,588 | $-1,786 | $60 | $-250,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 0 | N/A | 544 | N/A |
| Debt Repayment | -84 | -87 | -131 | N/A | -178 |
| Common Stock Issued | 15,613 | 179 | 94 | N/A | 245,025 |
| Other Financing Activity | -2,593 | 54,537 | 13,499 | 0 | 7,166 |
| Financing Cash Flow | $37,936 | $54,629 | $13,462 | $544 | $252,013 |
| Beginning Cash Position | 12,127 | 9,664 | 30,301 | 1,335 | N/A |
| End Cash Position | 8,875 | 12,127 | 9,664 | 201 | 1,335 |
| Net Cash Flow | $-3,252 | $2,463 | $-20,637 | $-1,134 | $1,335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,843 | -50,578 | -32,313 | -1,738 | -678 |
| Capital Expenditure | -345 | -588 | -655 | N/A | N/A |
| Free Cash Flow | -41,188 | -51,166 | -32,968 | -1,738 | -678 |